Sale!

GNB4 Gene CMTDIF Genetic Test

Original price was: $700.Current price is: $500.

-29%

The GNB4 Gene CMTDIF NGS Genetic DNA Test is a cutting-edge genetic screening tool designed to detect mutations in the GNB4 gene associated with Charcot-Marie-Tooth disease type 1F (CMTD1F). This comprehensive test utilizes next-generation sequencing (NGS) technology to identify specific genetic variations that cause this hereditary neurological disorder. Patients experiencing progressive muscle weakness, foot deformities, or sensory loss in extremities should consider this test for accurate diagnosis. The test provides crucial information for treatment planning and genetic counseling, helping families understand inheritance patterns. Results are typically available within 3-4 weeks from blood or DNA samples. This advanced diagnostic tool is available for $500 USD, offering significant savings from the regular $700 price.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

GNB4 Gene CMTDIF NGS Genetic DNA Test

Comprehensive Genetic Testing for Charcot-Marie-Tooth Disease

The GNB4 Gene CMTDIF NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the GNB4 gene that cause Charcot-Marie-Tooth disease type 1F (CMTD1F). This hereditary neurological condition affects peripheral nerves, leading to progressive muscle weakness and sensory loss. Our advanced testing methodology provides patients and healthcare providers with precise genetic information essential for accurate diagnosis and personalized treatment strategies.

What Does This Test Measure?

This sophisticated genetic analysis specifically targets the GNB4 gene, which encodes the guanine nucleotide-binding protein subunit beta-4. Mutations in this gene disrupt normal nerve function by affecting intracellular signaling pathways crucial for peripheral nerve maintenance and regeneration. The test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the entire GNB4 gene, detecting:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions
  • Copy number variations
  • Pathogenic variants associated with CMTD1F

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals exhibiting symptoms suggestive of Charcot-Marie-Tooth disease or those with a family history of hereditary neuropathies. Key indicators include:

  • Progressive muscle weakness in feet and hands
  • High-arched feet or other foot deformities
  • Reduced sensation in extremities
  • Difficulty with fine motor skills
  • Family history of similar neurological symptoms
  • Unexplained peripheral neuropathy
  • Progressive walking difficulties

Significant Benefits of Genetic Testing

Undergoing the GNB4 Gene CMTDIF NGS Genetic DNA Test offers numerous advantages for patients and their families:

  • Accurate Diagnosis: Provides definitive identification of CMTD1F, eliminating diagnostic uncertainty
  • Family Planning: Enables informed reproductive decisions through genetic counseling
  • Personalized Treatment: Guides development of targeted management strategies
  • Proactive Monitoring: Facilitates early intervention and symptom management
  • Genetic Counseling: Supports understanding of inheritance patterns and risk assessment
  • Research Contribution: Advances scientific understanding of hereditary neuropathies

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our genetic counseling team. Possible outcomes include:

  • Positive Result: Indicates the presence of pathogenic GNB4 gene mutations associated with CMTD1F
  • Negative Result: Suggests no detectable mutations in the GNB4 gene, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation

All results are accompanied by comprehensive genetic counseling to ensure complete understanding and appropriate next steps.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Focus: Neurological Disorders

Pre-Test Requirements

Before scheduling your test, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Understanding of potential outcomes and their significance

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about hereditary neurological conditions affect your quality of life. Our GNB4 Gene CMTDIF NGS Genetic DNA Test provides the answers you need for informed healthcare decisions. Contact us today to schedule your genetic counseling session and testing appointment.

Call or WhatsApp: +1(267) 388-9828

Our dedicated genetic specialists are available to answer your questions and guide you through the testing process. Take control of your neurological health with advanced genetic diagnostics from America’s trusted genetics laboratory.